glp-1 alzheimer's 2025 Repositioning Drugs for Neurologic Disease: Evidence, Advances, and Outlook | NeurologyLive GLP-1 Pipeline Update: August 2025

GLP-1: molecular mechanisms and outcomes of a complex signaling system

Mol Metab (2015) 4:71831

A 2023 study found that the antioxidant effects of silymarin can stimulate anti-tumor activities as well as protect healthy cells from damage induced by chemotherapy

Comprehensive cancer pre-screening represents a crucial component of patient evaluation due to the potential for these peptides to stimulate angiogenesis, which could theoretically promote malignant growth and metastasis

Typically, noticeable weight loss can begin within the first few weeks, with more significant progress occurring over several months

Tangvarasittichai S